| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1609484-45-8 | 4-Bromospiro(9H-fluorene-9,9'-(9H)xanthene) | C25H15BrO |
| 1609484-77-6 | N-((1,1'-Biphenyl)-3-yl)-(1,1':3',1''-terphenyl)-4'-amine | C30H23N |
| 1609584-72-6 | 1-(3-Methoxy-4-((6-((2-((1-methylethyl)sulfonyl)phenyl)amino)-9H-purin-2-yl)amino)phenyl)-4-piperidinol | C26H31N7O4S |
| 1609960-30-6 | 6-(2,3-Dichlorophenyl)-N4-methyl-2,4-pyrimidinediamine;TH 287 | C11H10Cl2N4 |
| 1609960-31-7 | N4-Cyclopropyl-6-(2,3-dichlorophenyl)-2,4-pyrimidinediamine;TH 588 | C13H12Cl2N4 |
| 1610413-97-2 | 12-(4-((9S,13S)-9,13-Bis(tert-butoxycarbonyl)-18,18-dimethyl-3,11,16-trioxo-17-oxa-2,4,10,12-tetraazanonadecyl)phenyl)acetic acid | C34H54N4O10 |
| 1610527-49-5 | 2,4-Dimethyl-1-((2-nitrophenyl)thio)benzene | C14H13NO2S |
| 1610882-30-8 | (2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-((4-pyridinylmethyl)amino)-1-butanone hydrochloride (1:1);TCS-OX 2-29 | C23H31N3O3.HCl |
| 1611469-80-7 | 1-(3-Bromopropyl)-4-octylbenzene | C17H27Br |
| 1611490-64-2 | UDP-GlcNAz.2Na;Uridine 5-disphopho-N-acetylazidoglucosamine disodium salt | C17H24N6O17P2Na2 |
| 1611493-60-7 | Bictegravir;(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-hydroxy-7,9-dioxo-N-((2,4,6-trifluorophenyl)methyl)-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxamide; GS 9883 | C21H18F3N3O5 |
| 1612153-32-8 | (4R)-3-((5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl)-4-phenyl-2-oxazolidinone | C20H20FNO4 |
| 1612191-86-2 | (3alpha,5beta,6alpha,7alpha)-6-Ethyl-24-norcholane-3,7,23-triol | C25H44O3 |
| 1612888-66-0 | Alofanib;3-(((4-Methyl-2-nitro-5-(3-pyridinyl)phenyl)amino)sulfonyl)benzoic acid | C19H15N3O6S |
| 1613028-81-1 | N-(2-(3-Bromophenyl)ethyl)-2,4,6-trimethyl-N-((3'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)methyl)benzenesulfonamide | C31H32BrNO4S2 |
| 1613191-77-7 | 2-Amino-6-fluoropyrazolo(1,5-a)pyrimidine-3-carboxylic acid | C7H5FN4O2 |
| 1613373-33-3 | PCO371;1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethylimidazolidine-2,4-dione | C29H32F3N5O6S |
| 1613373-40-2 | 1-(4-Bromo-3,5-dimethylphenyl)-5,5-dimethylimidazolidine-2,4-dione | C13H15BrN2O2 |
| 1613439-62-5 | 1-(4-(5'-Chloro-3,5-dimethyl(2,4'-bipyridin)-2'-yl)-1-piperazinyl)-3-(methylsulfonyl)-1-propanone hydrochloride (1:1) | C20H25ClN4O3S.HCl |
| 1613695-14-9 | 2-(2-(3-Chloro-4-methoxyphenyl)ethyl)-5-(3,5-dimethyl-4-isoxazolyl)-1-((2S)-2-(4-morpholinyl)propyl)-1H-benzimidazole | C28H33ClN4O3 |
| 1613724-42-7 | 5,13-Dihydro-4,5,13-trimethyl-2-((1-(4-piperidinyl)-1H-pyrazol-4-yl)amino)-6H-naphtho(2,3-e)pyrimido(5,4-b)(1,4)diazepin-6-one | C26H28N8O |
| 1613751-69-1 | 2-Chloropyrrolo(2,1-f)(1,2,4)triazin-4(1H)-one | C6H4ClN3O |
| 1616113-45-1 | 8,8'-(1'-Acetylspiro(9H-fluorene-9,4'-piperidine)-2,7-diyl)bis(2,6-anhydro-7,8-dideoxy-D-glycero-D-manno-oct-7-ynitol) | C35H39NO11 |
| 1616340-68-1 | 5-((((2,4-Difluorophenyl)methyl)amino)carbonyl)-1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2-pyridinecarboxylic acid methyl ester | C20H22F2N2O7 |
| 1616391-65-1 | N-((2S)-3-(3,4-Dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl)-6-(3-oxetanylamino)-4-pyrimidinecarboxamide | C20H25N5O3 |
| 1616391-87-7 | 2-(Cyclobutylamino)-N-((2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl)-4-pyridinecarboxamide;EPZ 015866; GSK 3203591 | C22H28N4O2 |
| 1616493-44-7 | Tucidinostat;N-(2-amino-4-fluorophenyl)-4-((((E)-3-pyridin-3-ylprop-2-enoyl)amino)methyl)benzamide | C22H19FN4O2 |
| 1616499-37-6 | 2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole | C26H16ClN3 |
| 1616592-60-9 | Erythrinin F;(±)-O-Demethylanagyroidisoflavone A | C20H18O7 |
| 1616607-88-5 | 2-(2-Bromophenyl)-9-phenyl-9H-carbazole | C24H16BrN |
| 1616632-77-9 | 2,4,6,7,8,9-Hexahydro-4-((2-methylphenyl)methyl)-7-(phenylmethyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1H)-one | C24H26N4O |
| 1616703-93-5 | Ticagrelor EP Impurity C;2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate | C25H30F2N6O5S |
| 1616761-00-2 | (3R,4R)-3-((2-Chloro-7H-pyrrolo(2,3-d)pyrimidin-4-yl)methylamino)-4-methyl-beta-oxo-1-piperidinepropanenitrile | C16H19ClN6O |
| 1616967-26-0 | Formoterol EP Impurity E;N-(2-hydroxy-5-(1-hydroxy-2-((2-(4-methoxy-3-methylphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide | C20H26N2O4 |
| 1616979-93-1 | tert-Butylbis(3,5-di-tert-butylphenyl)phosphine | C32H51P |
| 1618657-31-0 | Ezetimibe Impurity 9;Xxzjuzxkbfupqh-ikggrygdsa-N; (2R,3R,6S)-6-(4-fluorophenyl)-2-(4-hydroxyphenyl)oxane-3-carboxylic acid | C18H17FO4 |
| 1619967-09-7 | (3,3'-Difluoro-(2,2'-bithiophene)-5,5'-diyl)bis(trimethylstannane);(4-fluoro-5-(3-fluoro-5-trimethylstannylthiophen-2-yl)thiophen-2-yl)-trimethylstannane | C14H20F2S2Sn2 |
| 1619994-68-1 | 1-(1-(2-(Methylsulfonyl)phenyl)-7-propoxy-3-indolizinyl)ethanone | C20H21NO4S |
| 1619994-69-2 | Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-(1,2,4)triazolo(4,3-b)pyridazin-8-yl)carbamate | C17H20N6O4S |
| 1620097-06-4 | (5R)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine | C13H20N2 |
| 1620401-82-2 | 6,7-Dimethoxy-2-(1-pyrrolidinyl)-N-(5-(1-pyrrolidinyl)pentyl)-4-quinazolinamine | C23H35N5O2 |
| 1620458-09-4 | Zoliflodacin;(4'R,6'S,7'S)-17'-fluoro-4',6'-dimethyl-13'-((4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl)spiro(1,3-diazinane-5,8'-5,15-dioxa-2,14-diazatetracyclo(8.7.0.02,7.012,16)heptadeca-1(17),10,12(16),13-tetraene)-2,4,6-trione | C22H22FN5O7 |
| 1620576-64-8 | 1-(4-(5-(5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1H-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one | C22H31N9O3 |
| 1621085-33-3 | 3-Methyl-N-((phenylmethoxy)carbonyl)-L-valine compd. with 2-propanamine | C14H19NO4.C3H9N |
| 1621175-65-2 | N-(3-Chloro-4-(((2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl)amino)methyl)phenyl)methanesulfonamide | C18H19ClN6O2S |
| 1621274-17-6 | DPPF Pd G4;(SP-4-3)-(1-(Diphenylphosphino-?P)-1'-(diphenylphosphino)ferrocene)(methanesulfonato-?O)(2'-(methylamino-?N)(1,1'-biphenyl)-2-yl-?C)palladium | C48H43FeNO3P2PdS |
| 1621274-19-8 | (SP-4-3)-((5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl)diphenylphosphine-κP)(methanesulfonato-κO)(2'-(methylamino-κN)(1,1'-biphenyl)-2-yl-κC)-Palladium;XantPhos Pd G4 | C53H47NO4P2PdS |
| 1621681-63-7 | Cabozantinib N-oxide;1-N-(4-(6,7-dimethoxy-1-oxidoquinolin-1-ium-4-yl)oxyphenyl)-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | C28H24FN3O6 |
| 1622008-73-4 | 4,4'-(2,3-Dihydrothieno(3,4-b)-1,4-dioxin-5,7-diyl)bis(N,N-bis(4-methoxyphenyl)-benzenamine) | C46H40N2O6S |
| 1622173-72-1 | Cinacalcet Impurity 50 HCl;N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride | C22H25ClF3N |